Abstract
Inhibitory neurotransmission in the brain is largely mediated by GABAA receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (α1 H101R) with a diazepam-insensitive α1 subtype and a selective BZ site ligand, L-838,417, to explore GABAA receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the α1 subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABAA receptor subtypes in distinct neuronal circuits.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barnard, E. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313 (1998).
Sieghart, W. Structure and function of γ-aminobutyric acidA receptor subtypes. Pharmacol. Rev. 47, 181–234 (1995).
Pritchett, D. B., Luddens, H. & Seeburg, P. H. Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. Science 245, 1389–1392 (1989).
Pritchett, D. B. & Seeburg, P. H. γ-Aminobutyric acid A receptor α5-subunit creates novel type II benzodiazepine pharmacology. J. Neurochem. 54, 1802–1804 (1990).
Wieland, H. A., Luddens, H. & Seeburg, P. H. A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. J. Biol. Chem. 267, 1426–1429 (1992).
Rudolph, U. et al. Benzodiazepine actions mediated by specific γ-aminobutyric acid A receptor subtypes. Nature 410, 796–800 (1999).
Soriano, P., Montgomery, C., Geske, R. & Bradley, A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693–702 (1991).
Rosahl, T. W. et al. Short-term synaptic plasticity is altered in mice lacking synapsin I. Cell 75, 661–670 (1993).
Rosahl, T. W. et al. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375, 488–493 (1995).
Schwenk, F., Baron, U. & Rajewsky, K. A. cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080–5081 (1995).
Fritschy, J. M. & Mohler, H. GABAA-receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359, 154–194 (1995).
Wisden, W., Laurie, D. J., Monyer, H. & Seeburg, P. H. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12, 1040–1062 (1992).
Duggan, M. J. & Stephenson, F. A. Biochemical evidence for the existence of γ-aminobuyrate A receptor iso-oligomers. J. Biol. Chem. 265, 3831–3835 (1990).
McKernan, R. M. et al. GABAA receptors immunopurified from rat brain with alpha subunit specific antibodies have unique pharmacological properties. Neuron 7, 667–676 (1991).
Luddens, H. et al. Cerebellar GABAA receptor selective for a behavioural alcohol antagonist. Nature 346, 648–651 (1990).
Wisden, W. et al. Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunit. FEBS Lett. 289, 227–230 (1991).
Triet, D. Animal models for the study of anti-anxiety agents: a review. Neurosci. Biobehav. Rev. 9, 203–222 (1985).
Dawson, G. R. & Tricklebank, M. D. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol. Sci. 16, 33–36 (1995).
Broughton, H. et al. patent WO 98/04559 (1998).
Hadingham, K. L. et al. Stable expression of mammalian type A gamma-aminobutyric acid receptors in mouse cells: demonstration of functional assembly of benzodiazepine-responsive sites. Proc. Natl. Acad. Sci. USA 89, 6378–6382 (1992).
Hadingham, K. L. et al. Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acid A receptor subunit and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acid A receptors. Mol. Pharmacol. 43, 970–975 (1993).
Bayley, P. J., Bentley, G. D., Jackson, A., Williamson, D. & Dawson, G. R. Comparison of benzodiazepine (BZ) receptor agonists in two rodent activity tests. J. Psychopharmacol. 10, 206–213 (1996).
Atack, J. R., Smith, A. J., Emms, F. & McKernan, R. M. Regional differences in the inhibition of mouse in vivo [3H]Ro 15–1788 binding reflect selectivity for α1 versus α2 and α3 subunit-containing GABAA receptors. Neuropsychopharmacology 20, 255–262 (1999).
Fritschy, J. M. et al. Five subtypes of type A γ-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc. Natl. Acad. Sci. USA 89, 6726–6730 (1992).
Gao, B., Fritschy, J. M., Benke, D. & Mohler, H. Neuron-specific expression of GABAA-receptor subtypes: differential association of the α1- and α3-subunits with serotonergic and GABAergic neurons. Neuroscience 54, 881–892 (1993).
Sauer, B. Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol. 225, 890–900 (1993).
Quirk, K., Gillard, N. P., Ragan, C. I., Whiting, P. J. & McKernan, R. M. Model of subunit composition of gamma-aminobutyric acid A receptor subtypes expressed in rat cerebellum with respect to their alpha and gamma/delta subunits. J. Biol. Chem. 269, 16020–16028 (1994).
Sur, C., Fresu, L., Howell, O., McKernan, R. M. & Atack, J. R. Autoradiographic localization of alpha5 subunit-containing GABAA receptors in rat brain. Brain Res. 822, 265–270 (1999).
Sur, C. et al. Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acid A receptor in rat thalamus. Mol. Pharmacol. 56, 110–115 (1999).
Laurie, D. J., Seeburg, P. H. & Wisden, W. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J. Neurosci. 12, 1063–1076 (1992).
Collinson, N. & Dawson, G. R. On the elevated plus-maze the anxiolytic-like effects of 5-HT1A agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT1A partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635. Psychopharmacology 132, 35–43 (1997).
Wisden, W. & Stephens, D. N. Towards better benzodiazepines. Nature 401, 751–752 (1999).
Whiting, P. J. et al. Neuronally restricted RNA splicing regulates the expression of a novel GABAA receptor subunit conferring atypical functional properties. J. Neurosci. 17, 5027–5037 (1997).
Kehne, J. H. Cassella J. V. & Davis M. Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. Psychopharmacology 94, 8–13 (1988).
Acknowledgements
The authors acknowledge the continued support of F. Hefti and R. Hill. We also thank Richard Newman and G. O'Meara for assessment of animals and P. Wingrove for binding studies on recombinant α1 H101R.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McKernan, R., Rosahl, T., Reynolds, D. et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype. Nat Neurosci 3, 587–592 (2000). https://doi.org/10.1038/75761
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/75761
This article is cited by
-
Schisandrin B, a dual positive allosteric modulator of GABAA and glycine receptors, alleviates seizures in multiple mouse models
Acta Pharmacologica Sinica (2024)
-
Comparison of different weight-based scalars of remimazolam tosylate for anesthesia induction in obese patients: study protocol for a prospective, controlled trial
Trials (2023)
-
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder
Translational Psychiatry (2023)
-
Dopaminergic and cholinergic modulation of the amygdala is altered in female mice with oestrogen receptor β deprivation
Scientific Reports (2023)
-
The pyridazine heterocycle in molecular recognition and drug discovery
Medicinal Chemistry Research (2023)